Skip to content

Clinical Trial of Yuanli Needle Shu Acupuncture at Jugu Point for Cold-Damp Blockage Periarthritis of Shoulder

Clinical Trial of Yuanli Needle Shu Acupuncture at Jugu Point for Cold-Damp Blockage Periarthritis of Shoulder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002401
Enrollment
Unknown
Registered
2025-12-06
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periarthritis of Shoulder

Interventions

Control Group:Conventional Acupuncture at Regular Acupoints
Intervention Group 1:Treatment with Yuanli Needle Shu Acupuncture at Jugu Point+Conventional Acupuncture at Regular Acupoints
Intervention Group 2:Treatment with Filiform Needle Superficial Puncture at Jugu Point+Conventional Acupuncture at Regular Acupoints

Sponsors

Yichang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for periarthritis of shoulder and cold-damp blockage syndrome.(2) Aged between 40 and 70 years old, regardless of gender.(3) All have clear imaging evidence of lesions.(4) No medications or other treatments for periarthritis of shoulder were administered within 1 month prior to enrollment.(5) Voluntarily participate in the clinical trial and sign the informed consent form. Note: Only patients who meet all the above 5 criteria can be included in this study.

Exclusion criteria

Exclusion criteria: 1) Patients with definite bony lesions confirmed by imaging examinations;2) Patients with unconsciousness, inability to express subjective discomfort symptoms, accompanied by severe depression, anxiety symptoms or mental illnesses;3) Patients who received acupuncture treatment or underwent shoulder joint surgery within the past 30 days;4) Patients with a history of acute trauma to the neck, shoulder and back; those with shoulder pain caused by cervical spondylosis, rotator cuff injury, rheumatic diseases or other conditions;5) Patients with progressive malignant tumors or other severe consumptive diseases, who are prone to complicated infections and bleeding;6) Patients with comorbid primary diseases of the cardiovascular, liver, kidney, digestive, hematopoietic systems, etc.;7) Patients who have been exposed to teratogenic doses of radiation, poisons or drugs and are in the active phase, or have bad habits such as alcoholism or drug abuse;8) Patients with poor treatment compliance who are difficult to cooperate with pain rehabilitation treatment;9) Patients currently participating in other clinical research projects. Note: Patients who meet any of the above criteria shall be excluded from the study.

Design outcomes

Primary

MeasureTime frame
VAS Pain Score;

Secondary

MeasureTime frame
Shoulder Joint Function Score - Constant-Murley Scoring Scale;Vital Signs:Body Temperature ,Heart Rate ,Blood Pressure,Body Mass Index;Massachusetts General Hospital Acupuncture Sensation Scale,MASS;Range of Motion of the Shoulder Joint;

Countries

CHINA

Contacts

Public ContactHuaping Lei

Yichang Hospital of Traditional Chinese Medicine

43223985@qq.com15090878393

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026